Virtu Financial LLC Invests $607,000 in CME Group Inc (CME)
Virtu Financial LLC purchased a new position in CME Group Inc (NASDAQ:CME) during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 3,563 shares of the financial services provider’s stock, valued at approximately $607,000.
Several other large investors have also added to or reduced their stakes in CME. FDx Advisors Inc. bought a new stake in CME Group in the third quarter valued at about $390,000. Edgewood Management LLC increased its holdings in CME Group by 9.5% in the third quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock valued at $1,460,830,000 after buying an additional 742,067 shares during the last quarter. Independent Advisor Alliance bought a new stake in CME Group in the third quarter valued at about $208,000. Boston Private Wealth LLC increased its holdings in CME Group by 425.2% in the third quarter. Boston Private Wealth LLC now owns 91,850 shares of the financial services provider’s stock valued at $15,633,000 after buying an additional 74,360 shares during the last quarter. Finally, D.A. Davidson & CO. increased its holdings in CME Group by 1.7% in the third quarter. D.A. Davidson & CO. now owns 29,907 shares of the financial services provider’s stock valued at $5,091,000 after buying an additional 500 shares during the last quarter. Institutional investors and hedge funds own 85.89% of the company’s stock.
NASDAQ:CME opened at $187.11 on Friday. The company has a market cap of $64.24 billion, a PE ratio of 39.23, a P/E/G ratio of 2.19 and a beta of 0.46. CME Group Inc has a 52 week low of $143.68 and a 52 week high of $197.08. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.
Several analysts recently weighed in on the company. Barclays assumed coverage on CME Group in a report on Tuesday. They issued an “overweight” rating and a $210.00 price objective for the company. Zacks Investment Research lowered CME Group from a “buy” rating to a “hold” rating in a report on Friday. Atlantic Securities assumed coverage on CME Group in a report on Wednesday, November 28th. They issued a “neutral” rating and a $200.00 price objective for the company. BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a report on Tuesday, October 9th. Finally, Deutsche Bank boosted their price objective on CME Group from $205.00 to $206.00 and gave the company a “buy” rating in a report on Friday, November 16th. Six equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $194.13.
In other news, insider Julie Winkler sold 5,847 shares of the business’s stock in a transaction that occurred on Friday, November 16th. The stock was sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the completion of the transaction, the insider now directly owns 24,255 shares in the company, valued at $4,729,967.55. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Martin J. Gepsman sold 300 shares of the business’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $172.30, for a total value of $51,690.00. Following the transaction, the director now owns 42,912 shares of the company’s stock, valued at $7,393,737.60. The disclosure for this sale can be found here. Insiders have sold 29,800 shares of company stock valued at $5,628,462 over the last ninety days. Corporate insiders own 0.43% of the company’s stock.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Further Reading: Diversification For Individual Investors
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.